Whitney Ijem

Senior Vice President, Strategy & Business Development • Krystal Biotech

Whitney Ijem is SVP, Strategy and Business Development at Krystal. Before Krystal, she was a Managing Director and Senior Biotechnology Analyst covering genetic medicine and rare disease companies at Guggenheim Securities. Prior to Joining Guggenheim, Ms. Ijem was a therapeutics analyst at Tourbillon Capital where she focused on companies across the therapeutics space. Prior to Tourbillon, she was an analyst in the J.P. Morgan Equity Research Healthcare group focused on biotechnology. Before joining J.P. Morgan, Ms. Ijem was a biotech analyst at Canaccord Genuity. She holds a B.S. in Biomedical Engineering from Washington University in St. Louis and a M.S. in Biomaterials Science from New York University.

Also Speaking

Craig Shepherd

Senior Managing Director • Blackstone Life Sciences

Stefanos Theoharis

Chief Business Officer • Bone Therapeutics

Anthony Oliva

Senior Scientist • Longeveron

Event Info


Fun Run